Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guobo Shen

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Environmental Toxicology and Pharmacology|December 5, 2016
In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrowGuoping Wang, Guobo Shen, Tao Yin
Chinese Medical Journal|August 4, 2025
Neoantigen-driven personalized tumor therapy: An update from discovery to clinical applicationNa Xie, Guobo Shen, Canhua Huang, et al.
Oncology Research|July 14, 2015
HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer ModelTao Yin, Sisi He, Guobo Shen, et al.
Scientific Reports|May 16, 2014
Polyclonal rabbit anti-human ovarian cancer globulins inhibit tumor growth through apoptosis involving the caspase signalingShuang Zhang, Min Yu, Hongxin Deng, et al.
Frontiers in Immunology|December 18, 2023
Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatmentXiaohan Guo, Yi Wu, Ying Xue, et al.
Experimental and Therapeutic Medicine|June 9, 2020
Assessment of para-inflammation in a wound healing modelGuoping Wang, Guobo Shen, Xiaoshuang Jiang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 5, 2024
mRNA therapies: Pioneering a new era in rare genetic disease treatmentGuobo Shen, Jian Liu, Hanmei Yang, et al.
Molecular Medicine Reports|June 23, 2015
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer modelTao Yin, Sisi He, Guobo Shen, et al.
Translational Oncology|April 19, 2014
Antiangiogenic therapy using sunitinib combined with rapamycin retards tumor growth but promotes metastasisTao Yin, Sisi He, Tinghong Ye, et al.
Signal Transduction and Targeted Therapy|January 5, 2023
Neoantigens: promising targets for cancer therapyNa Xie, Guobo Shen, Wei Gao, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Environmental Toxicology and Pharmacology|December 5, 2016
In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrowGuoping Wang, Guobo Shen, Tao Yin
Chinese Medical Journal|August 4, 2025
Neoantigen-driven personalized tumor therapy: An update from discovery to clinical applicationNa Xie, Guobo Shen, Canhua Huang, et al.
Oncology Research|July 14, 2015
HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer ModelTao Yin, Sisi He, Guobo Shen, et al.
Scientific Reports|May 16, 2014
Polyclonal rabbit anti-human ovarian cancer globulins inhibit tumor growth through apoptosis involving the caspase signalingShuang Zhang, Min Yu, Hongxin Deng, et al.
Frontiers in Immunology|December 18, 2023
Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatmentXiaohan Guo, Yi Wu, Ying Xue, et al.
Experimental and Therapeutic Medicine|June 9, 2020
Assessment of para-inflammation in a wound healing modelGuoping Wang, Guobo Shen, Xiaoshuang Jiang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 5, 2024
mRNA therapies: Pioneering a new era in rare genetic disease treatmentGuobo Shen, Jian Liu, Hanmei Yang, et al.
Molecular Medicine Reports|June 23, 2015
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer modelTao Yin, Sisi He, Guobo Shen, et al.
Translational Oncology|April 19, 2014
Antiangiogenic therapy using sunitinib combined with rapamycin retards tumor growth but promotes metastasisTao Yin, Sisi He, Tinghong Ye, et al.
Signal Transduction and Targeted Therapy|January 5, 2023
Neoantigens: promising targets for cancer therapyNa Xie, Guobo Shen, Wei Gao, et al.
Pageof 7